Vitamin K supplementation may reduce risk of development of type 2 diabetes Medha Baranwal29 Sept 2023 11:15 AM ISTChina: A systematic review and meta-analysis published in the journal Food and Function has shed light on the relationship between vitamin K and type...
Once-weekly insulin icodec with dosing guide app showed superior HbA1c reduction versus once-daily insulin in phase 3a trial Dr. Kamal Kant Kohli27 Sept 2023 8:00 PM ISTIn the Phase 3a ONWARDS 5 randomized trial, once-weekly insulin icodec titrated with a dosing guide app demonstrated superior reduction in HbA1c...
Medical Bulletin 27/September/2023 Isra Zaman27 Sept 2023 3:15 PM ISTHere are the top medical news of the day:Tirzepatide outperforms Semaglutide in controlling Blood Sugar and Weight Loss in Type 2 Diabetes A new...
DPP4 inhibitor cetagliptin effective and well-tolerated for treating patients with type 2 diabetes Medha Baranwal27 Sept 2023 11:45 AM ISTChina: A randomized double-blind, placebo-controlled phase 3 trial has shed light on the safety and efficacy of cetagliptin as monotherapy in patients...
Tirzepatide outperforms Semaglutide in controlling Blood Sugar and Weight Loss in Type 2 Diabetes Isra Zaman27 Sept 2023 9:00 AM ISTA new meta-analysis of 22 studies, presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany,...
Tirzepatide found more effective for control of blood sugar and body weight than semaglutide Dr. Kamal Kant Kohli25 Sept 2023 11:45 AM ISTResearchers at Aristotle University of Thessaloniki, Thessaloniki, Greece have found in a new meta-analysis that tirzepatide is superior to...
Type of dietary protein not as important as overall weight loss among patients with type 2 diabetes Dr. Kamal Kant Kohli23 Sept 2023 11:45 AM ISTUSA: A recent study published in the journal Obesity has suggested that achieved weight loss should be the principal target of dietary interventions...
Breast Cancer Treatments Linked to Increased Risk of Type 2 Diabetes Jacinthlyn Sylvia23 Sept 2023 11:00 AM ISTA new study published in Breast Cancer Research and Treatment raised concerns about the potential link between breast cancer and an increased risk of...
FDA Approves Empagliflozin for CKD treatment, regardless of diabetes status Dr. Kamal Kant Kohli23 Sept 2023 10:45 AM ISTThe US Food and Drug Administration has approved another SGLT2 Inhibitor Empagliflozin for treatment of CKD regardless of diabetes status.Jardiance®...
Medical Bulletin 22/September/2023 Isra Zaman22 Sept 2023 3:15 PM ISTHere are the top medical news of the day:Morning and afternoon workouts better for diabetes prevention shows study A recent study published in...
Exercise during Morning and afternoon slightly better than evening for prevention of diabetes Dr. Kamal Kant Kohli22 Sept 2023 11:00 AM ISTPhysical activity is a preventive factor for type 2 diabetes, but its timing and consistency in contrast with overall sum of physical activity has...
Plasma growth hormone mediators associated with poor blood sugar control in youth with type 2 diabetes Dr. Kamal Kant Kohli22 Sept 2023 9:15 AM ISTUSA: A recent study has shed light on the associations of growth hormone (GH) mediators (e.g., growth hormone receptor (GHR), insulin-like growth...
